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Abstract
The goal of the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA)
Stroke Recovery working group is to understand brain and behavior relationships
using well-powered meta- and mega-analytic approaches. ENIGMA Stroke Recovery
has data from over 2,100 stroke patients collected across 39 research studies and
10 countries around the world, comprising the largest multisite retrospective stroke
data collaboration to date. This article outlines the efforts taken by the ENIGMA
Stroke Recovery working group to develop neuroinformatics protocols and methods
to manage multisite stroke brain magnetic resonance imaging, behavioral and demo-
graphics data. Specifically, the processes for scalable data intake and preprocessing,
multisite data harmonization, and large-scale stroke lesion analysis are described, and
challenges unique to this type of big data collaboration in stroke research are dis-
cussed. Finally, future directions and limitations, as well as recommendations for
improved data harmonization through prospective data collection and data manage-
ment, are provided.
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1 | INTRODUCTION
Stroke results in neural damage to the brain and subsequent physical,
cognitive, and emotional deficits (Dimyan & Cohen, 2011; Meyer
et al., 2015; Ward, 2017). Globally, there are over 13.7 million new
strokes each year, and stroke is a leading cause of adult long-term dis-
ability (Benjamin et al., 2018; Johnson et al., 2019; Lindsay et al., 2019).
Since stroke is a vascular disease, there is vast heterogeneity in both
brain and behavioral changes across patients, posing a significant chal-
lenge to the development of effective stroke neurorehabilitation strate-
gies (Bernhardt et al., 2016). The recovery process also contributes to
additional interindividual variability in the time course and extent of the
resolution of neural damage and behavioral deficits.
Given the heterogeneity in both injury and recovery, large sam-
ples of diverse patients are needed to accurately study processes
related to and supporting stroke recovery. However, a recent system-
atic review suggested that most studies seeking to determine the best
predictors of stroke recovery are underpowered (Kim &
Winstein, 2017). This is in part because acquiring large datasets of this
nature is logistically and financially prohibitive for a single stroke
research site. Recognizing these challenges, the Stroke Recovery and
Rehabilitation Roundtable (SRRR) task force developed consensus
statements on how to move stroke recovery research forward
(Bernhardt et al., 2016; Bernhardt et al., 2019). Two key priority areas
include: (a) a better understanding of the neurobiology of spontane-
ous and treatment-dependent recovery in humans; and
(b) characterizing different stroke recovery phenotypes (Bernhardt
et al., 2017), with a long-term goal of identifying potential biomarkers
that predict stroke recovery (Boyd et al., 2017). Here, we describe the
steps that the Enhancing Neuroimaging Genetics through Meta-
Analysis (ENIGMA) Stroke Recovery working group has taken to
address these priorities using a unique, big data approach with an
emphasis on reliable and reproducible methods.
The ENIGMA worldwide consortium consists of over 1,400
researchers from 45 countries who have come together to form
26 different disease working groups as well as 24 additional working
groups to study healthy human variation and develop novel, robust
methods for neuroimaging and genetic meta-analyses
(Thompson, 2019; Thompson et al., 2019; Thompson et al., 2020).
Formed in 2009, ENIGMA has resulted in significant, large-scale con-
tributions on the neural correlates of major depression (Schmaal
et al., 2016), schizophrenia (Van Erp et al., 2018), bipolar disorder
(Hibar et al., 2016), obsessive–compulsive disorder (Boedhoe
et al., 2016), and epilepsy (Whelan et al., 2018). ENIGMA methods,
discussed in this article, have also resulted in some of the largest stud-
ies of genetic correlates of specific brain characteristics, such as
genetic variations determining subcortical, hippocampal, and intracra-
nial brain volumes (Grasby et al., 2020; Hibar et al., 2015; Stein
et al., 2012). In order to analyze multisite data in these large studies,
ENIGMA typically uses a meta-analytic approach in which analysis
methods, which are tested for reliability across diverse research sites,
are openly shared. Participating research sites can analyze their brain
magnetic resonance imaging (MRI) and genetic data locally and share
either their site results (meta-analysis) or individual participant results
(mega-analysis) with the rest of the working group (Zugman
et al., 2020). In this way, many research sites can be brought together
to meta- and mega-analyze retrospective MRI and genetic data col-
lected across different research sites around the world. The devel-
oped methods perform consistently despite high variability in MRI
scanner manufacturers, scanner strengths, and pulse sequences, and
the same methods can be applied across different disease working
groups, allowing for cross-disorder comparisons despite using differ-
ent acquisition protocols (Boedhoe et al., 2019).
The ENIGMA Stroke Recovery working group is one of the 26 dis-
ease working groups within the ENIGMA consortium. Initially devel-
oped by a small group of researchers in 2015, ENIGMA Stroke
Recovery has grown to over 100 members and has amassed a dataset
of 2,137 MRI scans and counting from 39 research studies across
10 countries (see Table 1 for a summary of the number of scans by
institution and geographical region at the time of publication). A
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primary goal of ENIGMA Stroke Recovery is to provide a reliable
infrastructure for the collection and analysis of large, diverse datasets
of poststroke brain MRI and behavioral data across research laborato-
ries worldwide. The focus of the ENIGMA Stroke Recovery working
group was initially on understanding the neural correlations of post-
stroke sensorimotor performance, which is affected in up to 80% of
individuals after stroke (Rathore, Hinn, Cooper, Tyroler, &
Rosamond, 2002). However, this focus has diversified as new mem-
bers have joined. ENIGMA Stroke Recovery currently includes mea-
sures of sensorimotor, cognitive, emotional, and psychosocial
behavior. Both ischemic and hemorrhagic stroke are included in the
database, along with demographic, clinical and bedside diagnostic
information. ENIGMA Stroke Recovery uses pipelines developed by
several of the ENIGMA methods working groups (for a recent review,
see Thompson et al., 2020, as well as other widely used software
packages (Fischl et al., 2002; Fischl & Dale, 2000; Smith et al., 2004;
Smith et al., 2007). Given the diversity and the unique challenges
associated with stroke-specific brain imaging data, discussed further
in the article, the ENIGMA Stroke Recovery working group also
requests raw MRI data when available. The raw data are processed by
ENIGMA Stroke Recovery research staffs who perform additional
quality control and lesion segmentation steps. Reliable and robust sys-
tems for data collection and maintenance are thus critical for the suc-
cess of this collaborative approach.
The ENIGMA Stroke Recovery database can be used for many
different purposes. First, the data can be used to test whether brain–
behavior relationships identified in smaller, more homogeneous sam-
ples also exist in larger, more diverse samples. A specific example
might be examining whether individuals with left hemisphere stroke
show better or worse outcomes than those with right hemisphere
stroke, as reports from the literature on this topic are inconsistent
(Beuscher et al., 2017; Macciocchi, Diamond, Alves, & Mertz, 1998;
Ween, Alexander, D'Esposito, & Roberts, 1996; Wu et al., 2015). Sec-
ond, these data can be used to identify characteristics, such as specific
lesion locations that affect stroke outcomes of interest. For example,
the data could be used to identify whether depression is more com-
mon following a stroke that impacts the left frontal cortex, or whether
injury to specific cortical regions, such as the right dorsal premotor
region, is associated with differences in functional outcomes. The data
could also be used in a voxel-wise analysis to identify voxels
(i.e., three-dimensional pixels) in the poststroke brain that are related
to a specific behavior, such as spasticity, mild cognitive impairment or
poststroke fatigue. This voxel-wise whole-brain approach provides a
granular way to examine entire vascular territories, not limited by spe-
cific anatomical boundaries. A third use of the data is in generating
new data-driven hypotheses using machine-learning methods. The
large size of the dataset makes it uniquely powered for machine-
learning methods, which require big datasets to train and test com-
puter algorithms to identify patterns. In particular, this dataset is well
suited for unsupervised machine-learning techniques, which can be
used to identify clusters, or subgroups, of people who show similar
patterns of recovery, and then examine what brain traits are common
within those specific subgroups. Notably, as all of the data provided in
ENIGMA Stroke Recovery is collected for specific research studies,
the secondary use of these data in ENIGMA Stroke Recovery reduces
research waste and improves the efficiency and speed with which we
can test the reproducibility of existing research findings, identify novel
brain–behavior relationships, and generate data-driven hypotheses.
In this article, we provide a comprehensive description of the
ENIGMA Stroke Recovery working group's approach to large-scale
analyses of multisite retrospective poststroke brain MRI and behav-
ioral data for the broad neuroscience community. Specifically, this
article will discuss methods and protocols developed for: (a) data
intake, (b) data harmonization, and (c) lesion analysis. In each section,
we also highlight future directions and recommendations to facilitate
collaborative data sharing (see also Box 1).
TABLE 1 Number of T1-weighted MRI scans by geographical
region/institute
Country City Institute
Number
of scans
Australia Melbourne The Florey Institute of
Neuroscience and Mental
Health
317
Brazil Sao Paolo University of Sao Paolo 28
Brazil Sao Paolo Albert Einstein Israeli
Hospital
15
Canada Toronto University of Toronto/
Sunnybrook Research
Institute
29
China Tianjin Tianjin Medical University
General Hospital
65
Germany Griefswald University of Griefswald 68
Germany Tübingen University of Tübingen 175
Italy Rome IRCCS Santa Lucia
Foundation
192
New Zealand
Auckland University of Auckland 104
Norway Oslo University of Oslo 265
UK London University College London 50
USA Atlanta Emory University 110
USA Charleston Medical University of South
Carolina
174
USA College
Park
University of Maryland 128
USA Irvine University of California,
Irvine
191
USA Los Angeles University of Southern
California
189
USA Philadelphia University of the Sciences 37
Total scans 2,137
Note: The total number of T1-weighted MRI scans (N = 2,137) includes
data from both individuals with stroke (n = 1,918, or 89.8% of the total
dataset) and healthy individuals (n = 219, or 10.2% of the total dataset). A
subset of the scans also includes repeated MRIs from the same individual
(e.g., longitudinal data; n = 672 scans, or 31.4% of the total dataset).
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2 | DATA INTAKE
2.1 | Data components
Key components for the initial ENIGMA Stroke Recovery analyses rely
on a T1-weighted (T1w) anatomical brain MR image and at least one
poststroke behavioral outcome measure. These two elements com-
prise the minimum data required to join ENIGMA Stroke Recovery.
Demographic data are also strongly requested, although not required.
A summary of all data components is included in Table 2. Each com-
ponent is described in more depth below.
2.1.1 | Magnetic resonance imaging
The high-resolution T1w MRI is used to quantify anatomical variation
in regions across the brain, which is then related to the behavioral
measures. We use a T1w MRI instead of other MR sequences, which
might be more sensitive to the stroke lesion acutely, because high-
resolution T1w MRIs are routinely collected during research studies
and can be used with FreeSurfer, a software used by all ENIGMA
working groups for structural MRI analysis. FreeSurfer performs auto-
mated cortical and subcortical brain segmentation (Fischl et al., 2002;
Fischl & Dale, 2000) and has reliable performance across different
scanner characteristics and T1w acquisition parameters (Han
et al., 2006). However, we acknowledge that the T1w MRI is not the
best choice for identifying the lesion volume in acute and subacute
patients. Therefore, we also collect additional MRI data that can be
received and combined for analysis, such as diffusion MRI,
T2-weighted fluid-attenuated inversion recovery (FLAIR), as well as
other modalities of interest, such as resting-state functional
MRI (fMRI).
If raw MRI data cannot be shared, research sites can choose to
analyze the data locally using processing scripts found on the
ENIGMA website (http://enigma.ini.usc.edu/protocols/); results can
then be sent for subsequent analyses (outputs include a spreadsheet
with measures of cortical thickness, cortical surface area, and subcor-
tical volumes following FreeSurfer segmentation). However, the
ENIGMA Stroke Recovery group has the complicating issue of lesions
within the data (see Section 4). Therefore, more stringent quality con-
trol, as well as delineation of stroke lesion boundaries, is required for
more fine-grained analyses of the lesion's impact on subsequent brain
structure and behavior. For this reason, sites not sending raw data are
requested to send the FreeSurfer segmentation measures, along with
quality control images generated by our in-house code (see Section 2.2
for more detail), and lesion masks normalized to a standard template
brain when possible.
2.1.2 | Behavioral data
ENIGMA Stroke Recovery collects many different types of behavioral
data. As mentioned previously, the focus of the initial research ques-
tion is on the neural correlates of poststroke sensorimotor behavior.
To this end, over 80% of the dataset includes measures of sensorimo-
tor performance. However, the growth and diversification of the
ENIGMA Stroke Recovery group has led to the collection of additional
types of behavioral data, including measures of cognition, mood, dys-
phagia, and psychosocial well-being (see Section 3 for more
information).
2.1.3 | Demographic data
Demographic information on the participants is also collected, such as
age, sex, time from last known well to imaging, type of stroke, number
of previous strokes, stroke location, risk factors, and comorbidities
(see Section 3 for more information). There are no exclusionary demo-
graphic criteria for entry into the database. There is growing interest
in characterizing rehabilitation history, although this is an extremely
complex variable to harmonize across research sites and encode. In
BOX 1 ENIGMA Stroke Recovery Working
Group recommendations for prospective
data collection, data management, and
data sharing
1 Add language in ethics protocols and informed consent
forms for data sharing (see Appendix 2).
2 Use standardized protocols for MRI data collection, fol-
lowing either the Human Connectome Project's Lifespan
Aging protocol (https://www.humanconnectome.org/
study/hcp-lifespan-aging/project-protocol/imaging-
protocols-hcp-aging) or the Alzheimer's Disease Neuro-
imaging Initiative protocol (http://adni.loni.usc.edu/
methods/mri-tool/mri-analysis/) where possible.
3 Collect Stroke Recovery and Rehabilitation Roundtable
(SRRR) task force consensus-based demographic vari-
ables and behavioral measures as prescribed (e.g., do not
modify the measure to exclude certain items or include
extra items). See Kwakkel et al. (2017) for a complete list
of sensorimotor measures and McDonald et al. (2019) for
recommendations for cognitive measures (McDonald
et al., 2019).
4 Use the Brain Imaging Data Structure (BIDS) format to
name, describe, organize and store all data (https://bids.
neuroimaging.io/; Gorgolewski et al., 2016).
5 Share full research protocols on an open platform like
Open Science Framework to improve the replicability of
experiments (https://osf.io/).
6 Consider openly sharing data to increase the reach and
impact of any collected data (Nichols et al., 2017).
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general, the reported demographic variables can be included as
covariates or inclusion/exclusion criteria for specific analyses.
2.2 | Data intake workflow
When a research site joins ENIGMA Stroke Recovery, the site
securely transfers de-identified MRI data as well as a comma-
separated values (CSV) spreadsheet with all demographic and behav-
ioral outcomes. If the raw MRI data are not available or cannot be
shared, the site can run analyses scripts locally (https://github.com/
npnl/ENIGMA-Wrapper-Scripts) and send FreeSurfer results in a CSV
file along with the behavioral/demographic CSV file. Transfer can be
accomplished via a secure file transfer protocol to an ENIGMA Stroke
Recovery dedicated Linux server, or by the research site's preferred
secure transfer method (e.g., using Box). The complete process, from
data intake to data analysis, is displayed in Figure 1 and described in
brief below. The scripts and code developed for these processes are
freely and publicly available on Github (https://www.github.
com/npnl).
First, the received data are manually inspected to ensure: (a) good
MRI data quality, and (b) appropriate values for the behavioral data.
For MRI data quality, we visually inspect the images to ensure there
are not large motion artifacts or other visible sources of noise in the
data. Data that are of poor quality are excluded from the database.
More recently, to standardize this process, we have begun to use the
University of Southern California's Laboratory of Neuroimaging
(LONI) Quality Control system, which is a freely available,
semiautomated, web-based system for quantitatively evaluating MRI
image quality (Kim et al., 2019). We ensure that the behavioral data
are appropriately coded according to our ENIGMA Stroke Recovery
database conventions. For instance, we convert and record time since
stroke in units of days and denote the lesioned hemisphere by an inte-
ger value where left = 1, right = 2, both = 3, and other = 4. The behav-
ioral data are also inspected for values within the normal range for
each measure. For the initial analysis of sensorimotor outcomes, a
“primary” sensorimotor outcome that most closely aligns with the
existing ENIGMA dataset is selected (see Section 3 for details). Alto-
gether, these steps ensure that the incoming data are consistent with
the existing database for subsequent analysis.
Next, we write a site-specific script to reformat the data to con-
form to the Brain Imaging Data Structure (BIDS; https://bids.
neuroimaging.io/) (Gorgolewski et al., 2016). BIDS provides a stan-
dardized way to organize and describe neuroimaging and behavioral
data. If the data are not consistently named and formatted within
each site, we manually reformat the data to conform to the BIDS
standard. Having all of the data in BIDS format allows us to quickly
and easily analyze ENIGMA Stroke Recovery data using a variety of
software tools, many of which are written with the assumption that
the data are in BIDS format (Gorgolewski et al., 2017). It also allows
all of the code and scripts created for ENIGMA Stroke Recovery
analyses to be easily used by others who use BIDS format, thereby
increasing the transparency, reproducibility, and impact of
this work.
Third, we run FreeSurfer, a brain imaging software package devel-
oped to analyze MRI scans, which segments the brain into anatomical
regions for morphometric analysis (Fischl et al., 2002). We run two
versions of FreeSurfer (version 5.3 and version 6.0) on the MRI data
using scripts that automate the processing of all participants in parallel
on the LONI computing cluster. FreeSurfer version 5.3 is currently the
primary analysis version, which is used to maintain consistency with
recent ENIGMA working group analyses. We also analyze all raw data
TABLE 2 Data elements collected by the ENIGMA Stroke Recovery working group
MRI Behavior Demographics
Required T1-weighted structural MRI
Scanner strength, brand, and model
Alternative if unable to share raw T1 MRIs:
A spreadsheet with FreeSurfer cortical
and subcortical measurements, quality
control 2D image slices, and lesion
masks (registered to a standardized
template)
At least 1 behavioral outcome measure
Most common measures at time of
publication:
• Fugl-Meyer Assessment (72%)
• NIH Stroke Scale (19%)
• Motor Activity Log (16%)
• Modified Ashworth (12%)
• Action Research Arm Test (11%)
• Wolf Motor Function Test (9%)
None required
Most common demographics at time of
publication:
• Age
• Sex
• Time since stroke/last known well
(in days)
• Lesioned hemisphere
Recommended • FLAIR
• Diffusion MRI
• Resting-state fMRI
• Lesion masks
• Longitudinal scans
• EEG
We suggest collecting measures
recommended by the Stroke Recovery
and Rehabilitation Roundtable
(Bernhardt et al., 2017)
Current recommendations for
sensorimotor outcomes can be found
in Kwakkel et al. (2017)
Current recommendations for cognitive
outcomes can be found in McDonald
et al. (2019)
• First stroke or multiple strokes
• Race/ethnicity
• Hand dominance prior to stroke
• Therapy received (hours per week)
• Risk factors for cardiovascular disease
(e.g., hypertension, obesity, diabetes
smoking)
• Dementia status
• Comorbidities
Note: The data elements are divided into three main components: MRI, behavioral measures, and demographic data, and further separated into required
versus recommended elements.
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using FreeSurfer version 6.0 because this more recent version has
been shown to have improved performance and more accurate brain
segmentations compared to FreeSurfer version 5.3. In addition,
FreeSurfer version 6.0 also provides improved hippocampal segmen-
tations and analysis of hippocampal subfields in stroke (Khlif
et al., 2018), which is an area of research interest given recent findings
from our ENIGMA Stroke Recovery working group showing a rela-
tionship between poststroke sensorimotor behavior and hippocampal
volumes (Zavaliangos-Petropulu et al., 2019).
We then use the ENIGMA scripts mentioned previously to extract
standard measures of subcortical volume (from eight subcortical
regions of interest, bilaterally), and cortical thickness and cortical sur-
face area (from 34 cortical regions of interest, bilaterally; https://
github.com/npnl/ENIGMA-Wrapper-Scripts). All regions are from the
standard Desikan-Killany atlas implemented in FreeSurfer (Desikan
et al., 2006). These measures provide insight into brain morphometry
for both subcortical and cortical regions. ENIGMA scripts are used to
generate images of the overlap between each segmented region of
interest and the underlying brain and put these into a webpage that
can be visually inspected for segmentation accuracy. This is done for
each brain. Although FreeSurfer has shown acceptable poststroke
brain segmentation performance (Li et al., 2015), it may occasionally
fail to create accurate segmentations on lower quality data (e.g., MRIs
with lower spatial resolution or greater noise from movement) or on
data with lesions that disrupt its surface-based algorithms. In our
ENIGMA Stroke Recovery dataset, FreeSurfer fails to produce accu-
rate segmentations in 10–20% of the data. To address this, trained
researchers manually inspect each region of interest for each brain
MRI. Any regions that are not properly segmented by FreeSurfer are
marked as “failed” and excluded from the analyses (see Appendix 1 for
additional information about the ENIGMA Stroke Recovery
FreeSurfer quality control protocol).
Finally, we use an in-house script that pulls all of each site's
FreeSurfer outputs and behavioral data and enters them into a rela-
tional database using Structured Query Language (SQL). Data are
entered into a SQLite database (https://sqlite.org), a free, relational
database engine that allows for simple and intuitive data storage
using the SQL language (Owens, 2006). Key benefits of a SQL-based
environment—compared to other database options, such as REDCap
(Harris et al., 2009) (https://www.project-redcap.org/)—are that it is
freely available (not institutionally constrained) and widely used
across both research and industry, leading to many options for inte-
grating SQL analyses with popular programming environments such
as Python, and statistical packages such as R. SQLite runs quickly
and does not require specialized computing resources, and SQLite
databases can be easily shared. SQL-based databases are also being
used in other large-scale data sharing projects, such as the NIH-
funded All of Us research initiative, which aims to gather health-
related data about one million or more people living in the United
States (Klann, Joss, Embree, & Murphy, 2019). Given these factors,
SQLite provides an accessible option for scalable data analysis and
for future data sharing and is aligned with existing big data initia-
tives. Within the SQLite database, there are seven tables that hold
information about demographics, behavioral measures, brain mea-
sures (two tables, one for each of the FreeSurfer analysis versions),
MR scanner information, research site information, and metadata
about the database itself. This database is queried to extract the
specific data used in each analysis.
F IGURE 1 ENIGMA Stroke Recovery workflow. Workflow for ENIGMA Stroke Recovery from data intake to data analysis
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2.3 | Future directions for improving data intake
A key future priority for updating the data intake process is using arti-
ficial intelligence to improve the manual quality control process, capi-
talizing on the efforts from other ENIGMA working groups (Petrov
et al., 2017; Petrov et al., 2018). Currently, performing visual quality
control of each segmented FreeSurfer region is a significant bottle-
neck in our data intake pipeline. Each individual brain has a total of
84 subcortical and cortical regions that should be inspected by a
trained investigator, which takes on average about 20 min per brain;
performing quality control on so many regions manually is not easy to
scale up. In addition, visual quality control is an inherently subjective
process. Investigators are intensively trained to ensure good inter-
rater reliability, but there is still the potential for human error.
Machine-learning algorithms to reliably perform quality control of the
segmentations would remove an enormous barrier to performing this
work. To facilitate the development of an automated quality control
process, we have manually generated ratings on the subcortical vol-
umes of over 1,000 poststroke brain MRIs to date. We anticipate that
these data can be used to train and test deep learning algorithms
(such as convolutional neural networks) to identify failures in
segmentation.
3 | DATA HARMONIZATION
A second key challenge that ENIGMA Stroke Recovery faces is har-
monizing data collected using different MRI scanners and scanning
protocols, as well as using different behavioral outcome measures.
Data harmonization refers to all efforts to combine data collected
across different sources and with different formats, naming conven-
tions, and measures into one cohesive dataset. Optimizing data har-
monization is important because MRI data collected using different
scanners and/or scanning protocols can significantly affect analyses
and results [e.g., (Zavaliangos-Petropulu et al., 2019)]. For behav-
ioral data, different measures may focus on measuring specific
aspects of sensorimotor impairment, function, or quality, and maybe
more or less sensitive to a certain range of performance values.
Importantly, the harmonization of methods also provides an oppor-
tunity to explore the effects of inter-site differences on both MRI
and behavioral data analysis, which is difficult to examine otherwise.
Here, we describe efforts to address each of these challenges so
that we can combine imaging scans and behavioral data obtained at
different centers.
3.1 | MRI harmonization
ENIGMA working groups have developed robust methods for analyz-
ing T1w anatomical MRIs, diffusion MRI, and resting-state fMRI in a
way that is reproducible and reliable across multiple research sites
(Acheson et al., 2017; Jahanshad et al., 2013; Pizzagalli et al., 2019).
While the scans themselves are not directly combined, a number of
specific metrics are extracted from each type of imaging sequence so
that data across centers can be used in mega- and meta-analyses. The
key measures extracted for each sequence are described below. In
addition, we provide guidelines for quality control and harmonization
in order to ensure that all segmentations are representative of the
desired anatomy. In this way, even if the scans themselves are not
combined, statistical approaches for combining these extracted fea-
tures in a meta-analytical or mega-analytical manner can be taken.
Detailed instructions and code for analysis and quality control for
each method may be found on the ENIGMA website (http://enigma.
ini.usc.edu/protocols/imaging-protocols/).
3.1.1 | T1-weighted MRI
As noted previously, a T1w MRI is a key component of the initial
ENIGMA Stroke Recovery analyses. T1w MRIs are processed using
ENIGMA's structural image processing protocols (publicly available in
the link above), which include several methods for analyzing T1w
MRIs including cortical and subcortical volume and surface area, sulcal
geometry analysis, and vertex-wise subcortical shape analysis. The
ENIGMA structural protocols all utilize outputs from FreeSurfer, a
brain imaging software package developed to analyze MRI scans of
brain tissue, which segments and labels neuroanatomical structures in
the data (Fischl et al., 2002). Importantly, FreeSurfer is reliable across
research sites and demonstrates good test–retest reliability across
scanner manufacturers and field strengths (Han et al., 2006). In addi-
tion, as mentioned above in Data Intake (Section 2.2), we perform
manual quality control on all FreeSurfer segmentations, so that subse-
quent structural analyses use only quality-controlled inputs. Trained
researchers manually inspect each region of interest for each struc-
tural brain MRI. Regions that are not properly segmented by
FreeSurfer are marked as “failed” and excluded from further analysis
(see Appendix 1 for the full ENIGMA Stroke Recovery FreeSurfer
quality control protocol).
3.1.2 | Diffusion MRI
The ENIGMA-DTI protocol is used to study fractional anisotropy and
diffusion tensor imaging-derived diffusivity measures of whole brain
and atlas-defined regions of interest in the white matter, based on the
tract-based spatial statistics method implemented in FMRIB Software
Library (Smith et al., 2007). While preprocessing diffusion MRI can
vary by data quality, the ENIGMA-DTI protocol provides suggestions
including steps for motion correction, echo-planar imaging distortion
correction, and tensor fitting. The ENIGMA-DTI protocol can be
found on the ENIGMA website (http://enigma.ini.usc.edu/protocols/
dti-protocols/) and is detailed elsewhere (Jahanshad et al., 2013). This
protocol has been shown to have excellent reproducibility between
scanners for the analysis of white matter microstructure (Acheson
et al., 2017). The ENIGMA-DTI working group also works on methods
for harmonizing multisite diffusion MRI (Zhu, Moyer, Nir, Thompson, &
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Jahanshad, 2018), and the ENIGMA Stroke Recovery group will use
recently recommended mega-analytic methods for diffusion MRI ana-
lyses (Boedhoe et al., 2019).
3.1.3 | Resting-state fMRI
Resting-state fMRI (rs-fMRI) offers an approach to understand pat-
terns of synchronized brain activity in the resting state, which can fur-
ther be decomposed into networks with known functions (e.g., default
mode, salience, attention networks) (Biswal et al., 2010; Biswal,
Yetkin, Haughton, & Hyde, 1995). Harmonized processing of rs-fMRI
in ENIGMA has used one of two pipelines: (a) an echo-planar imaging-
based pipeline, based on the Analysis of Functional NeuroImages soft-
ware, which does not require the use of a co-registered anatomical
MRI dataset (Adhikari et al., 2018; Adhikari et al., 2019; Adhikari
et al., 2019); and (b) a pipeline known as fMRIprep+, based on the
fMRIprep approach (Esteban et al., 2019), which can also be used for
the analysis of multisite task-based fMRI (Veer, Waller, Lett, Erk, &
Walter, 2019).
3.1.4 | Future Directions in Brain Imaging
Harmonization
Future directions include the harmonization of stroke electroencepha-
lography (EEG) data, as the ENIGMA EEG working group is currently
developing methods for analyzing resting-state EEG (Smit, 2020; Smit
et al., 2016). EEG has garnered growing attention in stroke rehabilita-
tion over the years due to its portability, safety, and lower cost, com-
pared to MRI or fMRI. Advancing our capability to use EEG was also
identified as a developmental priority in the SRRR taskforce on bio-
markers (Boyd et al., 2017). EEG measures, such as hemispheric asym-
metry or frontoparietal coherence, have also been related to and/or
predictive of stroke outcomes (Ramos-Murguialday et al., 2013; Zhou
et al., 2018).
Finally, although all our existing MRI pipelines offer methods for
handling previously collected data, the ideal scenario is a harmonized
prospective data collection. We recommend that individual research
groups consider using MRI sequences that match the publicly avail-
able sequences from the NIH-funded Lifespan Human Connectome
Project Aging group https://www.humanconnectome.org/study/hcp-
lifespan-aging/project-protocol/imaging-protocols-hcp-aging) or the
NIH-funded Alzheimer's Disease Neuroimaging Initiative (ADNI;
(http://adni.loni.usc.edu/methods/mri-tool/mri-analysis/). Doing so
would expand the reach of one's individual research data by allowing
for comparison with large, existing datasets, and help align prospec-
tive scanning efforts in ENIGMA Stroke Recovery with that of other
groups. Future work may also try to align the ENIGMA diffusion MRI
and rs-fMRI data processing protocols with the UK Biobank imaging
efforts, which aim to provide multimodal brain imaging data on
100,000 individuals living in the United Kingdom (Alfaro-Almagro
et al., 2018).
3.2 | Behavioral and demographic data
harmonization
3.2.1 | Behavioral data
Stroke researchers test a broad range of hypotheses, and different
behavioral outcomes are selected to address specific hypotheses. In
addition, the same behavior may be assessed using multiple measures.
Thus, although many researchers in the ENIGMA Stroke Recovery
working group study poststroke arm performance, the current
ENIGMA Stroke Recovery database has more than 75 unique behav-
ioral measures. This large number of behavioral measures is in line
with a study reporting that 144 different outcome measures were
used to study poststroke arm rehabilitation across 243 clinical trials
(Duncan Millar, van Wijck, Pollock, & Ali, 2019).
In order to organize the many different types of behavioral data,
ENIGMA Stroke Recovery relies on the International Classification of
Functioning, Disability and Health (ICF) (World Health
Organization, 2001), which provides a framework that can be used to
categorize different assessments of poststroke outcomes. The ICF
model has three levels that can be used to conceptualize behavioral
measurements about a person: (a) body functions and structures
(measuring the person's impairment), (b) activities (measuring function
at the level of the person), and (c) participation (measuring function of
the person as a member of society). The ICF framework is used by the
SRRR task force to categorize core measures for all stroke recovery
trials to collect (Kwakkel et al., 2017). Specifically, the SRRR recom-
mends collecting the Fugl-Meyer Assessment (FMA) (Fugl-Meyer,
Jaasko, Leyman, Olsson, & Steglind, 1975) to measure body function
and structure for the upper and lower limbs, and the Action Research
Arm Test (ARAT) (Lyle, 1981) and a 10-min walk test to measure
activity limitations in the upper and lower limbs. Although there was
no consensus recommendation on participation, there were recom-
mendations to collect the EuroQoL 5 dimension scale (EQ-5D) as a
measure of quality of life (Brooks & Group, 1996) and the modified
Rankin Scale as a measure of global disability (Van Swieten, Koudstaal,
Visser, Schouten, & Van Gijn, 1988). Finally, the National Institutes of
Health Stroke Scale (NIHSS) (Brott et al., 1989) was recommended to
measure stroke severity (i.e., global impairment across multiple
domains), but not as an outcome measure.
These ICF-based and SRRR-recommended measures are well rep-
resented in the ENIGMA Stroke Recovery database. The most com-
mon measures include (listed in order of frequency in the database
with percent frequency in parentheses): (a) FMA-UE (72%), (b) NIHSS
(19%), (c) Motor Activity Log (MAL; 16%,) (Uswatte, Taub, Morris, Vig-
nolo, & McCulloch, 2005), (d) modified Ashworth measure of spastic-
ity (12%) (Bohannon & Smith, 1987), (e) ARAT (11%), and (f) Wolf
Motor Function Test (WMFT; 9%) (Wolf et al., 2001). Notably, the
most common measures focus on sensorimotor performance of the
upper extremity after stroke, which reflects the research focus of
the many ENIGMA Stroke Recovery working group members who
study this topic. As the working group grows more diverse, so too do
the behavioral measures. At present, the database also includes
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measures of gait and balance, such as the 6-min walk test (Butland,
Pang, Gross, Woodcock, & Geddes, 1982), cardiovascular fitness, such
as VO2 max (Shephard et al., 1968), cognition (e.g., Mini-Mental State
Examination (Folstein, Robins, & Helzer, 1983), Montreal Cognitive
Assessment (Nasreddine et al., 2005), and mood [e.g., the Hospital
Anxiety and Depression Scale (Zigmond & Snaith, 1983)].
Prospectively, we recommend that stroke researchers collect all
of the measures recommended by the SRRR task force (Kwakkel
et al., 2017), with a particular emphasis on the FMA, which is con-
tained in 72% of entries in our database and thus the most well-
represented measure. However, given that ENIGMA Stroke Recovery
currently contains only retrospective data, there are several ways that
we maximize this data, despite the different behavioral measures.
For our initial study of sensorimotor outcomes, for each site, we
define a primary sensorimotor score, which is the measure from the
site that is the most widely reported measure in the database. For
instance, if a site collected the ARAT, nine-hole pegboard test, and
grip strength, we would use the ARAT as the primary sensorimotor
score, since, of the three collected by that site, it is the best represen-
ted within the ENIGMA Stroke Recovery database across all sites.
Using this measure, we then take a percentage of the maximum possi-
ble score for that measure, where 0% is the worst sensorimotor out-
come and 100% is the best. For example, if someone received a 33 on
the ARAT (where the maximum score is 57), their primary sensorimo-
tor score would be 58%. Doing this also addresses the variability in
how people collect even standardized measures. For instance, some
research sites do not collect the full FMA-UE because they do not
agree with the reflex measures. The maximum possible score for the
site might then be 60 instead of the full FMA-UE scale of 66. Calculat-
ing a percentage of the maximum possible sensorimotor score allows
for the normalization of different behavioral scores, enabling a com-
parison across participants from different research studies. A limita-
tion of our approach is that it mixes measures of sensorimotor
impairment, function, and participation, examiner- versus patient-
reported outcomes, and different times after stroke that may be more
or less ideal for a specific behavioral measure. We attempt to over-
come this limitation by also grouping measures by the level of mea-
surement for analyses when possible: impairment (e.g., FMA-UE, grip
strength), function (e.g., ARAT, WMFT), and participation (e.g., MAL,
Stroke Impact Scale). Lastly, we analyze the most commonly reported
measures separately. Although this last approach limits the sample
size for these analyses, it allows for a more rigorous examination of
the neural correlates of specific measures (e.g., to study neural corre-
lates of impairment versus function or to examine differences
between examiner- versus patient-reported outcomes).
3.2.2 | Demographic variables
Many different demographic variables, such as age, sex, hemiparetic
side, and time since stroke, have been shown to strongly influence
poststroke behavioral outcomes (Appelros, Stegmayr, & Terént, 2009;
Chang, Chang, Cragg, & Cramer, 2013; Jongbloed, 1986; Stewart,
Gordon, & Winstein, 2014; Stinear et al., 2006; Stinear et al., 2017).
Similar to the behavioral outcome measures, the demographic vari-
ables collected across research sites and studies are also wide-ranging.
Within ENIGMA Stroke Recovery, the most consistently reported var-
iables are age, race, sex, time since stroke, and lesioned hemisphere.
Not surprisingly, these variables are reported with different levels of
granularity across research sites. For instance, time since stroke is
often reported in units of days, weeks, months, or even years. To max-
imize precision in at least a subset of the data, we convert time since
stroke to days for all (e.g., 2 months after stroke would be converted
to 61 days, calculated as 2 × 30.5 days on average per month). Nota-
bly, this reduces the precision of the data, especially if the time since
stroke is reported in years for some research studies, in which case
the value “2 years” could actually represent anywhere from 730 to
1,094 days. To this end, we strongly recommend collecting the
smallest unit of measurement possible. Additional variables are highly
useful as well, although less frequently reported, such as hand domi-
nance prior to the stroke, therapy received, risk factors for cardiovas-
cular disease such as hypertension, obesity, diabetes and smoking,
and comorbidities (including several of the aforementioned risk fac-
tors). The latter variables have been shown to affect the brain beyond
the lesion and may result in decreased white matter integrity and
increased structural atrophy.
3.2.3 | Future directions in behavioral measure and
demographic variable harmonization
We recommend that researchers prospectively conducting research fol-
low the SRRR task force recommendations regarding both behavioral
measurements and demographic variables, as well as the precision with
which to collect them (Kwakkel et al., 2017). As data collection of these
measures can be subjective, we also highly recommend standardized
training for the collection of behavioral measures. For example, previous
research has shown that training on how to administer and measure the
FMA-UE (See et al., 2013) can greatly improve measurement reliability
across different research sites. ENIGMA Stroke Recovery would also
benefit from increased reporting of behavioral measures beyond senso-
rimotor outcomes, such as measures of gait, balance, cognition, and psy-
chosocial health, as well as neuropsychiatric outcomes. Future
directions for this aspect of the dataset include harmonizing and model-
ing longitudinal data aggregated across research sites. This important
analysis would allow us to not only discuss sensorimotor behavior at a
single, cross-sectional timepoint but also sensorimotor recovery, which
by definition requires an examination of longitudinal changes over multi-
ple timepoints.
4 | LESIONS
Finally, in addition to harmonizing the measurement of brain volumes
and behavior across research sites, ENIGMA Stroke Recovery also has
to account for different types of brain lesions. There are two primary
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types of brain lesions encountered in stroke MRI data: those that are
a direct result of the stroke, and white matter lesions, also known as
white matter hyperintensities, which represent small vessel disease.
Both types of lesions are important to capture in stroke analyses, as
both have previously been associated with stroke outcomes across
cognitive and motor domains (Arsava et al., 2009; Auriat et al., 2019;
Boyd et al., 2017; Feng et al., 2015; Riley et al., 2011). While white
matter hyperintensities can be measured using automated software
(Ramirez et al., 2011), software to accurately and automatically iden-
tify stroke lesions still poses a significant challenge. This is because
the size, shape, and location of acute stroke lesions are more variable,
and thus less predictable, than white matter lesions, which typically
occur in the periventricular or deep white matter and are of a charac-
teristic shape and size. There is a strong scientific interest in under-
standing how stroke lesions both directly and indirectly (e.g., through
secondary degeneration) affect brain structure and, subsequently,
behavior. Therefore, the ENIGMA Stroke Recovery working group has
developed methods for accurately capturing the stroke lesion to char-
acterize both direct versus indirect effects of the lesion on the brain.
This section will detail the steps we have taken to develop a complete
neuroinformatics pipeline for large-scale, semiautomated stroke lesion
segmentation.
4.1 | An open-source stroke lesion dataset
The current gold standard for lesion segmentation using T1w MRIs is
manual segmentation (Ito, Kim, & Liew, 2019). When ENIGMA Stroke
Recovery started in 2015, there were few publicly available auto-
mated lesion segmentation methods for T1w MRIs. A key reason for
the small number of T1w lesion segmentation methods was the lim-
ited availability of open-source stroke MRI data with lesion masks that
could be used to develop, train, and test algorithms. Of the available
methods, most were developed on small datasets of individuals with
stroke (e.g., 8–60 patients) collected at one or two local research sites
(Griffis, Allendorfer, & Szaflarski, 2016; Pustina et al., 2016; Seghier,
Ramlackhansingh, Crinion, Leff, & Price, 2008). This lack of a large
public stroke lesion dataset has not only resulted in limited methods
for lesion segmentation but also resulted in methods that may have
limited generalizability to more diverse stroke datasets.
To address this problem, we developed a large, manually seg-
mented dataset of N = 304 stroke lesion masks and T1w brain MRIs
collected at eight different research sites around the world, which we
publicly released (Liew et al., 2018). The Anatomical Tracings of
Lesions After Stroke (ATLAS) dataset is the largest open-source
dataset of stroke anatomical MRIs and manually segmented lesion
masks (see Box 2). It is shared on two public repositories (ICPSR:
https://www.icpsr.umich.edu/icpsrweb/ADDEP/studies/36684; and
FCP/INDI: http://fcon_1000.projects.nitrc.org/indi/retro/atlas.html).
The procedure and training protocols for lesion segmentation are pub-
licly available (Liew et al., 2018). The purpose of releasing this dataset
was to provide a large, standardized test dataset, or benchmark, for
researchers to compare the performance of their lesion segmentation
algorithms with those of other research groups. Releasing this dataset
has now achieved the goal of improving lesion segmentation algo-
rithms and much more. It has been downloaded over 650 times by
individuals across more than 30 countries around the world and has
been used for educational, research, and industry projects. Toward
the primary goal, it has been published in papers reporting improved
automated lesion segmentation performance of more than 90%
accuracy (Sharique, Pundarikaksha, Sridar, Krishnan, & Krishnakumar,
2019). However, it has also been used in creative and unexpected
ways. It has been used as an example dataset in numerous university
classes on machine learning and computer vision and as a dataset for
masters and PhD theses. It has also led to the creation of new stroke
tools, such as probabilistic stroke atlas (Wang, Juliano, Liew, McKin-
ney, & Payabvash, 2019) and an in silico head model for stroke simula-
tion (Bing, Garcia-Gonzalez, Voets, & Jérusalem, 2020). These
unexpected uses highlight a key benefit of data sharing, which is that
sharing data can not only move research forward in ways that are
intended but can also lead to novel methods, data discovery and pow-
erful educational opportunities for trainees.
4.2 | Comparing automated lesion segmentation
methods
Using ATLAS, we systematically compared the existing, publicly avail-
able methods for lesion segmentation using T1w MRIs (Ito
BOX 2 ENIGMA Stroke Recovery Working
Group open-source tools for lesion
quality control and segmentation
1 ATLAS (Anatomical Tracings of Lesions After Stroke)
dataset—the largest open-source dataset of stroke ana-
tomical MRIs and manually segmented lesion masks (Liew
et al., 2018). It can be downloaded from two public
repositories:
 ICPSR (raw data): https://www.icpsr.umich.edu/
icpsrweb/ADDEP/studies/36684
 INDI (preprocessed data): http://fcon_1000.projects.
nitrc.org/indi/retro/atlas.html
2 PALS (Pipeline for Analyzing Lesions after Stroke) Toolbox—
an open-source toolbox for lesion analysis (Pipeline for
Analyzing Lesions after Stroke; PALS) (Ito et al., 2018).
 The PALS toolbox can be downloaded from Github:
https://www.github.com/npnl/PALS
3 Braindrles—a web-based platform for crowd-sourcing
manual quality control of lesion segmentations (Liew
et al., 2019).
 Braindrles can be played at https://braindrles.us/
 Source code for Braindrles can be found at https://
github.com/npnl/braindrles
12 LIEW ET AL.
et al., 2019). Although there are new methods constantly emerging
for lesion segmentation, most of these are not publicly available. Of
the existing methods available, we determined that Lesion Identifica-
tion with Neighborhood Data Analysis (LINDA) performed the best
(Pustina et al., 2016), with a median value on the Dice coefficient, or
measure of similarity between the LINDA segmentations and the gold
standard manual segmentations, of 0.5. LINDA performs extremely
well on larger lesions, which are the most time-consuming lesions to
manually segment. In ENIGMA Stroke Recovery, we therefore use
LINDA to generate initial lesion masks on all the data, and then per-
form manual quality control and manual correction on the resulting
lesion masks (see Box 2 for more details).
A key question regarding the adoption of automated lesion seg-
mentation techniques is: When is the automated lesion segmentation
method good enough to use? The answer to this question is deter-
mined by the research topic of interest and the research group. For
ENIGMA Stroke Recovery, a primary research focus is on under-
standing how lesion overlap with different brain structures relates
to specific behaviors. This can be performed by calculating a lesion
load (e.g., lesion overlap) with specific regions of interest, or at the
voxel-level, using methods like voxel-lesion symptom mapping to
examine whole-brain correlates of lesioned tissue within a stroke
cohort. Both of these approaches require precise lesion boundaries,
and we are therefore aiming for an automated lesion segmentation
method that performs with over 90% accuracy in the ENIGMA
Stroke Recovery dataset. As of December 2019, no publicly avail-
able automated lesion segmentation method has been able to meet
this threshold. When available, we request working group members
to submit their expert-drawn lesion masks with their MRI data.
When lesion masks do not exist, ENIGMA Stroke Recovery research
staff run LINDA on the MRIs and manually correct the resulting seg-
mentations. In all cases, we perform a careful visual inspection to
validate the quality of the segmentations.
Finally, as many recent methods have reported improved perfor-
mance (e.g., >90% accuracy on the ATLAS dataset) but have not
openly shared their methods, we are creating a web-based challenge
for research groups to evaluate their novel lesion segmentation
methods on a test dataset, for which the labeled data are hidden from
the contestants, similar to previous lesion challenges (Maier
et al., 2017). This challenge website is being built in collaboration with
researchers at the Paris-Saclay Center for Data Science using the
Rapid Analytics and Model Prototyping framework (https://ramp.
studio/), which will require the open sharing of the lesion segmenta-
tion method for entry, in order to encourage collaboration, transpar-
ency, and reproducibility (Kégl et al., 2018).
4.3 | Quality control and analysis of automated
lesion segmentation outputs
In order to manage the large volume of stroke lesion masks, we also
created an open-source toolbox for lesion analysis (Pipeline for Ana-
lyzing Lesions after Stroke; PALS) (Ito, Kumar, Zavaliangos-Petropulu,
Cramer, & Liew, 2018). The PALS toolbox can be downloaded from
Github (https://www.github.com/npnl/PALS) and installed locally (see
also Box 2). It has a function that creates a local quality control
webpage that shows each brain's lesion mask overlaid on the T1w
MRI. The webpage is interactive, and each lesion mask can be rated as
“good,” “maybe,” or “fail.” This sorts the lesions into the respective
folders, and any lesions that fall into the “maybe” or “fail” category are
manually corrected. In this way, a person can review hundreds of
lesion masks quickly and efficiently, without needing to open and
overlay each mask on each brain individually.
We also created a crowd-sourcing web-based platform called
Braindrles to engage citizen scientists in performing manual quality
control of automated lesion segmentation outputs (https://
braindrles.us/) (Liew et al., 2019; Box 2). Braindrles is built on the
same web-based platform as its predecessor, Braindr (Keshavan,
Yeatman, & Rokem, 2018). Braindrles presents dynamic gifs of a
lesion mask overlaid on a stroke brain, and users swipe right if they
believe the lesion mask is correct, and left if they believe it is incor-
rect or inaccurate. There is also an option to “chat” about the lesion
mask and ask questions. To encourage player engagement,
Braindrles is gamified with a leaderboard and levels based on the
number of swipes. Anyone in the public is welcome to play, and all
users are given a tutorial as well as feedback about their accuracy
on a subset of 100 stroke lesion masks. Because not all users are
expected to perform similarly (e.g., a lay person with no brain anat-
omy knowledge versus an experienced neuroradiologist), a machine
learning boosted tree-based algorithm called XGboost (Chen &
Guestrin, 2016) is used to identify and heavily weight raters who
are the most accurate. XGboost is also used to generate an aggre-
gate probability score from 0 (fail) to 1 (pass) for each lesion mask,
based on the weighted rater scores. To date, Braindrles contains
1,464 lesion masks generated by a mix of both automated and man-
ual segmentations and has garnered over 18,000 votes from over
100 users. Once fine-tuned, this platform will allow for a higher vol-
ume of quality control decisions on lesion segmentation outputs
and should provide a scalable solution as the project grows.
4.4 | Future directions for stroke lesion
segmentation
In the future, we aim to create an automated lesion segmentation
pipeline with embedded, automated quality control (see Figure 2).
This is critical because in addition to FreeSurfer segmentation
quality control (mentioned previously), manual lesion segmentation
and lesion quality control are the other major bottlenecks in the
analysis of large-scale stroke data. Manual lesion segmentation
and quality control is tedious, slow, and requires extensive exper-
tise, and it cannot be easily scaled up for thousands of stroke
brains. Thus, an automated pipeline in which manual input is only
needed to correct failed lesion masks would greatly accelerate the
pace of stroke research and could be used for small and large stud-
ies alike.
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5 | DISCUSSION AND FUTURE
DIRECTIONS
In this article, we have described the approaches and methods that
the ENIGMA Stroke Recovery working group has taken to facilitate
the establishment of the first large-scale collaborative multisite stroke
brain MRI and behavioral data analyses. We hope that these efforts
are useful in addressing key priorities in stroke research, including bet-
ter characterizing the neurobiology of stroke recovery in humans, and
identifying different stroke recovery phenotypes (Bernhardt
et al., 2017), with an ultimate goal of discovering biomarkers that pre-
dict stroke recovery (Boyd et al., 2017).
The work presented here is designed to ultimately improve our
ability to: (a) test whether brain–behavior relationships identified in
smaller, more homogeneous samples also exist in larger, more diverse
samples and (b) identify characteristics, such as specific lesion loca-
tions or specific demographics, which affect stroke outcomes of inter-
est. Toward these two aims, the data generated in ENIGMA Stroke
Recovery provide a valuable, standardized sample for researchers to
test findings reported in smaller studies on a larger, heterogeneous
dataset. Doing so may inform researchers of specific demographics or
eligibility criteria that may be critical for specific brain–behavior
relationships—a hypothetical example is finding that lesion overlap
with the parietal cortex may be significantly related to motor behavior
but primarily in people with chronic, right-hemisphere stroke. In this
way, ENIGMA Stroke Recovery's large data approach allows
researchers to ask not only “Is this true?” but also “For whom is this
true?” The importance of the latter question is that it accepts that
what is true for one person may not be true for another and strives to
identify individual differences in poststroke neural relationships
underlying sensorimotor performance. This approach aligns well with
the NIH's Precision Medicine Initiative, which recognizes that there
are individual differences in health and recovery and places impor-
tance on the personalization of healthcare wherever possible
(Collins & Varmus, 2015).
In addition, the exceptionally large size of this database affords
the statistical power to begin using supervised machine-learning tech-
niques to test and train models to predict sensorimotor outcomes and
to develop data-driven hypotheses. Unsupervised machine learning
can also be developed to identify clusters, or subgroups, of individuals
who show similar behavioral outcomes. These subgroups can then be
examined for similar traits that may relate to these outcomes.
Although the current size of the ENIGMA Stroke Recovery database
is relatively small compared to existing machine-learning
datasets, such as those used in Kaggle competitions (https://www.
kaggle.com/), it provides a beginning point for developing these
methods for stroke data, and will become more powerful as it grows.
Finally, while we have initially applied this framework toward
understanding the structural brain correlates of sensorimotor per-
formance, the infrastructure and tools created can now support
many additional questions and analyses. As noted throughout this
article, we have begun to expand the types of imaging sequences
and modalities collected across sites, as well as the behavioral mea-
sures, including cognitive, affective, psychosocial, and interpersonal
questionnaires. Scientists who are participating members of
ENIGMA Stroke Recovery can propose secondary analyses of the
data and partner with other members to ask questions that may
require a certain type of data or a specific behavioral outcome mea-
sure. ENIGMA Stroke Recovery provides a dynamic and growing
platform for international collaborations across diverse topics. Fur-
thermore, these collaborations are bound to extend beyond the
datasets with prespecified MRI characteristics as additional meth-
odologies emerge in the future to reconcile the variability across
sequences and to extract the data relevant to stroke recovery. For
instance, clinical MRI scans obtained during emergency hospitaliza-
tion for acute ischemic stroke provide an abundance of data related
to poststroke outcomes when analyzed using novel machine-
learning methods for stroke lesion segmentation on diffusion-
weighted imaging (Wu et al., 2019). Future artificial intelligence-
powered methodologies will allow researchers to optimize the anal-
ysis of these clinical scans and reconcile different types of data and
approaches for lesion segmentation. This will further enable the
growth and expansion of the stroke recovery database capabilities
and data utilization, ranging from “real-life” clinical scans to
research-protocol driven scans.
There are several current limitations of ENIGMA Stroke Recov-
ery's methods, which we are working to address. First, there are still
several manual steps that create a bottleneck in the processing pipe-
lines and limit the speed at which we can perform analyses, specifi-
cally regarding the quality control of brain segmentations (from both
F IGURE 2 Optimized lesion
segmentation pipeline. Example
of a future neuroinformatics
system for lesion segmentation,
with only one point of manual
input (manual segmentation of
failed lesion masks, indicated
in bold)
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FreeSurfer and the lesion masks). For instance, performing quality
control of just the FreeSurfer subcortical regions requires the manual
review of 16 regions per individual—or 16,000 regions for a dataset of
N = 1,000. Performing quality control of the FreeSurfer cortical
regions will require the review of an additional 68 regions per individ-
ual. We anticipate that with enough initial effort, we will be able to
generate sufficient data to effectively train machine-learning algo-
rithms to perform these tasks; however, at present, we have limited
the analyses to subcortical regions of interest and lesion analyses.
Second, the current methods (e.g., FreeSurfer) work best on high-
resolution scans (e.g., dimensions of isotropic 1 mm3 voxels) with min-
imal distortions or noise. However, we have access to over 14,000
clinically acquired stroke MRI scans, which typically have much lower
resolution (e.g., dimensions of 1 × 1 × 5 mm voxels); we thus need to
develop robust methods to organize and analyze these scans.
Although FreeSurfer does not work well on this type of data, other
methods, such as those examining white matter hyperintensities, ven-
tricular asymmetries, and total brain volume (Etherton et al., 2017;
Rost et al., 2018), as well as lesion overlap with standardized template
structures, may provide insights into the relationship between specific
disease states indicated by these measures and mortality and recov-
ery. Finally, the ENIGMA Stroke Recovery measures are limited to pri-
marily cross-sectional MRI and behavioral data, with a limited subset
of longitudinal data. Questions regarding neural recovery, as well as
the neural effects of specific interventions, are more difficult to
address because the duration between two time points and the nature
of the interventions administered varies widely across research sites.
Even within one intervention category, such as brain–computer inter-
faces or robotic interventions, there are different eligibility criteria for
entry into each study. Studies also vary in the total length of time and
number of treatment sessions during the study, as well as the specific
content of treatment (e.g., specific type of neurofeedback or robotic
intervention provided).
While there are significant challenges to harmonizing multisite
brain MRI and behavioral data after stroke, there are also many new
opportunities for the development of novel methods related to auto-
mated quality control and lesion segmentation, robust low-resolution
data analysis, and harmonized longitudinal analysis that may ultimately
improve our understanding of neural recovery after stroke. By openly
sharing our protocols and methods, we hope to provide useful tools
not only for ENIGMA Stroke Recovery but also for any stroke
researchers wishing to collaborate with others in the field. Overall, we
hope to improve the reproducibility of stroke research by reducing
barriers to collaboration and to accelerate the innovation and discov-
ery of more effective, personalized rehabilitation strategies for indi-
viduals after stroke.
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APPENDIX 1. ENIGMA STROKE RECOVERY QUALITY
CONTROL (QC) PROTOCOL
Quality control (QC) is done according to the ENIGMA subcortical
protocol for visual inspection. While other ENIGMA cohorts use
outlier detection to identify failed subcortical segmentations,
FreeSurfer segmentations of stroke participants merit additional
caution. Large stroke lesions may interfere with the image registra-
tion process (Yang et al., 2016) that takes place in FreeSurfer and
may cause poor subcortical segmentations that result in a skewed
distribution of volume estimates. For ENIGMA Stroke Recovery,
expert raters manually inspect subcortical segmentations for every
participant. Screenshots of nine slices of the brain (three coronal,
three axial, and three sagittal) are generated with bilateral segmenta-
tions overlaid onto the T1w MRI (left segmentation appears as
transparent blue, right segmentation as transparent red) for every
subcortical region for each subject. These screenshots are compiled
into eight separate web-based html files (one for each subcortical
region). These html files are then used to inspect segmentations for
quality.
Segmentations are scored as either PASS or FAIL depending on
segmentation quality (for examples, see Figure A1). The rater
documents the scores for every subcortical region in an excel spread-
sheet. Image quality is taken into consideration in the QC process;
excess motion or low resolution typically results in unreliable segmen-
tations and are more likely to be scored as FAIL. Segmentations that
underestimate the volume by not capturing the boundaries are scored
as FAIL. FreeSurfer tends to overestimate segmentations
(Schoemaker et al., 2016; Perlaki et al., 2017; Khlif et al., 2018), so
underestimated segmentations are typically severe and easy to detect.
Segmentations that overestimate by including neighboring regions are
also scored as FAIL. An example of a common overestimation that
includes a neighboring structure is a segmentation of the thalamus
that reaches into the adjacent third ventricle to capture choroid
plexus, the septum pellucidum, or the thalamus of the opposite hemi-
sphere. Transparency of the segmentation during the QC process is
crucial for detecting these kinds of overestimations. Segmentations
the rater is unsure of are opened in FreeSurfer viewer tkm-edit to
inspect the entire volume more closely.
All three views (coronal, axial, and sagittal) are considered in
determining the over- or under-estimation in order to consider the
segmentation as a three-dimensional structure. The coronal and axial
slices are primarily used for determining segmentation quality for all
subcortical segmentations. The sagittal view is mostly used as a
F IGURE A1 Examples of quality control decisions. (A) An axial view of a participant's left (blue) and right (red) caudate that are both scored
as PASS. (B) An axial view of an under segmented right caudate (FAIL). Lesion overlap in the caudate caused ambiguous gray matter boundaries,
resulting in a failed segmentation. (C) FreeSurfer can fail to segment correctly even without the presence of a lesion. This is an axial view of under
segmented left and right caudate segmentation that were scored as FAIL. (D) A coronal view of a participant's left and right caudate that are both
scored as PASS. (E) A coronal view of a participant with a lesion that overlaps with the left caudate creates ambiguous boundaries. In this case,
FreeSurfer overestimated the left caudate, mistaking the lesion as a gray matter boundary (FAIL)
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supplementary assessment of the quality of the caudate and the hip-
pocampus. The angle of the head is also taken into consideration dur-
ing QC- when the head appears to be tilted, bilateral segmentations in
the coronal view may appear heavily asymmetrical. By drawing an
imaginary horizontal line across the bilateral segmentations in one
slice (a coronal slice, for example) and predicting how the segmenta-
tions should appear in another slice (an axial slice), the rater can deter-
mine if the asymmetry is due to poor segmentation or head
placement.
Segmentations that overlap with lesions are scored as FAIL—the
intensity of voxels containing lesions and gray matter make it difficult
to differentiate gray matter boundaries. Lesions within close proxim-
ity to subcortical regions are at times mistaken for a boundary by the
FreeSurfer algorithm so the segmentation will overestimate to cap-
ture part of the lesion—this is scored as FAIL. Segmentations that
capture punctate lesions or perivascular spaces are also scored
as FAIL.
No more than 50 participants are inspected for each subcorti-
cal region at a time to keep raters consistent. Training a new rater
takes approximately 1 month. During the first week, the rater is
trained on 25 pre-identified participants with minimal pathology
to gain familiarity with good quality segmentations. During the
second and third weeks, they QC 50 additional participants with
a range of stroke pathology, flagging segmentations they are
unsure of for discussion. All 75 participants are then QCed a sec-
ond time during the fourth week to ensure intra-rater reliability.
An expert rater will check the new rater's QC ratings for the next
month until consistent inter-rater reliability greater than 0.9 is
achieved.
APPENDIX 2. LANGUAGE FOR DATA SHARING IN THE
ETHICS PROTOCOL AND INFORMED CONSENT FORM
Example Protocol Language
Data Collection and Monitoring
The researchers intend to keep the de-identified research data
indefinitely. This de-identified data may be shared with other
researchers for future analysis or shared in archives or databases.
Any data shared with other researchers will not include personal
identifying information.
Example Informed Consent Form Language
Data Storage and Retention
Research data will be maintained in paper format in a secure loca-
tion at the institution or electronically on secure, password-
protected computers and servers. Only authorized individuals will
have access to it, and all electronic data will be de-identified. The
researchers intend to keep the de-identified research data indefi-
nitely. Other researchers may have access to the de-identified data
for future research, and the de-identified data may be included in
future repositories or archives for use by other researchers. Your
information that is collected as part of this research will be used or
distributed for future research studies without your additional
informed consent. Any information that identifies you (such as your
name) will be removed from your private information before being
shared with others.
20 LIEW ET AL.
